Latest News about Partner Content
Recent news which mentions Partner Content
Investing In The Future: Understanding Lithium's Role And Capabilities In Advancing Battery Technologies
February 07, 2024
From Benzinga
Longeveron (NASDAQ: LGVN) Making Inroads With Lomecel-B™ – Biotech's Investigational Alzheimer's Treatment Shows Positive Trial Results
February 07, 2024
Tickers
LGVN
From Benzinga
Cannara Biotech Q1 Results: Revenue, Net Income And Market Share Up, Quarter Also Marks Company's First Export Sale
February 07, 2024
From Benzinga
From Benzinga
This Asset Class Is No Longer Just For The Elite
February 07, 2024
From Benzinga
Each Year, More Than 200 Workers Die From Silicosis; Laser Photonics' Innovative Technology Is Helping Make This A Thing Of The Past
February 07, 2024
Tickers
LASE
From Benzinga
Election Year Is Here: How To Make Organization's Voice Heard With VoterVoice From FiscalNote (NYSE: NOTE)
February 06, 2024
Tickers
NOTE
From Benzinga
Cboe Introduces Tuesday And Thursday Expiries For Russell 2000 And Mini-Russell 2000 Options
February 06, 2024
Tickers
CBOE
From Benzinga
India's Stock Market Growth In 2023: A Potential Prelude To Forex Growth? Navigate The Forex Wave With Octa
February 06, 2024
From Benzinga
Thinking Big With Nuvve's Vehicle-To-Grid Solution
February 06, 2024
From Benzinga
The Asian Cuisine Market Is Expected To Reach $233.3 Billion By 2030 – Here's How Steakholder Foods Is Increasing Seafood Supply To Meet Demand
February 06, 2024
Tickers
STKH
From Benzinga
Making Your Money Work For You: Generating 9-13% Potential Passive Income Through Real Estate Investing With DLP Capital
February 05, 2024
From Benzinga
Sick of Cold Calling? Emotionally Intelligent AI Could Help You Break Into The $325.7 Billion Market Opportunity Of MarTech
February 05, 2024
From Benzinga
CytoReason's AI-Driven Disease Model Platform Trusted By 5 Top 10 Pharma Companies Harnesses Big Data To Speed Drug Discovery And Development
February 05, 2024
From Benzinga
Elicio Therapeutics Announces Publication Of Preclinical Data Demonstrating Power Of Amphiphile-Immunotherapy
February 05, 2024
Tickers
ELTX
From Benzinga
How Alternative Recycling Models Like The One Offered By Aqua Metals (NASDAQ: AQMS) Could Be Key To The Shift To EVs And Sustainable Transportation
February 05, 2024
Tickers
AQMS
From Benzinga
Sienna Resources Expands Its Portfolio To Include Two Uranium Projects In The Athabasca Basin Region As Global Prices Hit A 16-Year High
February 05, 2024
From Benzinga
Speak And Be Saved: App Detects Heart Failure Weeks Before Attack
February 02, 2024
From Benzinga
Striking A Balance: Sustainable Phosphate Practices For A Growing World Population
February 02, 2024
From Benzinga
2 Million Cancer Diagnoses And 600,000 Cancer Deaths Expected In 2024 – Prevention Is Key To Treatment, And Mainz Biomed Is Leading The Charge
February 01, 2024
From Benzinga
Amesite Inc. In 2024: Growth, Partnership Building And Scaling A Zero Setup Cost AI-Driven Platform
January 31, 2024
From Benzinga
A New COVID-19 Variant Is Rapidly Spreading Around The Globe, Other Pandemic Threats Exist – What Are The Choices For Treatment?
January 31, 2024
From Benzinga
With An Anticipated Supply Gap, Has The Recent Sell-Off In Lithium Equities Created Opportunities For Investors?
January 31, 2024
From Benzinga
From Benzinga
Paws And Prosperity: Exploring U.S. Pet Services Growth And The Anticipated Surge In Annual Pet Spending From $980 To $1,292 By 2025
January 30, 2024
From Benzinga
High Indian Inflation Means Your Bank Savings Could Effectively Be Losing Value Sitting In Your Account – Make Your Money Work For You With Octa
January 30, 2024
From Benzinga
American Medical Association Grants Cardio Diagnostics (NASDAQ: CDIO) Reimbursement Codes For AI-Powered Coronary Heart Disease Tests
January 29, 2024
Tickers
CDIO
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.